A report published recently by Future Market Insights projects that the surgical drainage devices market will generate US$ 1.3 billion in sales globally by 2021. By 2032, the market is projected to be valued US$ 2.9 billion, growing at a compound annual growth rate of 7.7% between 2022 and 2032. With a compound annual growth rate (CAGR) of more than 7.8% from 2022 to 2032, Active Drainage Devices is predicted to be the most lucrative market.
Active drains are systems that collect fluid and deposit it in reservoirs. These reservoirs reduce hospital workers’ exposure to contaminated fluid. Active drains use an artificial pressure gradient to remove fluid from a wound or body cavity.
According to the National Library of Medicine, patients with active drains experienced 6% delayed healing compared to 54% for those with passive drains.
Active drains play an important role in improving the outcome of cardiothoracic surgeries, especially in children. As a result, the use of active surgical drain devices among a wide range of end-users has increased along with an increase in the prevalence of chronic diseases like arthritis and osteoporosis. This appears to be primarily driven by significant progress in the medical device industry.
Get a Sample Copy of the Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-15869
Impact of Covid-19 on the Surgical Drainage Devices Market
The pandemic disrupted routine hospital services all over the world. For patient safety, the hospital reduces the number of elective surgeries during the pandemic. Reduced elective surgery protected patients from viral transmission, but it reduced global demand for Surgical Drainage Devices. According to a British journal of surgery report, over 20 million elective surgeries were canceled during the pandemic.
Competitive Landscape
Some of the key players in Surgical Drainage Devices include Acelity, Teleflex Incorporated, Cardinal Health, Medtronic, Cook Medical, Johnson and Johnson, B. Braun Melsungen AG, Smith & Nephew plc, Stryker, Becton Dickinson, and Centese.
Some of the recent developments of key surgical drains devices providers are as follows:
- In October 2021, Centese created a self-cleaning chest tube device that offers more accurate measurements for keeping tabs on patients recuperating from heart or lung surgery. The device developed by Centese is called the Thoraguard device. This device will help Centese accelerate its growth in the segment of surgical drainage devices.
- In April 2019, Smith & Nephew plc announced the acquisition of Osiris Therapeutics, Inc. This addition will further accelerate the growth of Smith & Nephew’s surgical drains business and advance the wound care franchise.
- In October 2019, 3M announced the acquisition of Acelity, Inc.
Unlock Tailored Insights: Customize Your Report for Maximum Impact:
https://www.futuremarketinsights.com/customization-available/rep-gb-15869
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Surgical Drainage Devices Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.
The study reveals extensive growth in Surgical Drainage Devices Market in terms of Product Type (Active Drains, Passive Drains), Application (Thoracic and Cardiovascular Surgeries, Neurosurgical Procedures, Abdominal Surgery, Orthopedics, Other Applications.) by End use (Hospitals, Ambulatory Surgical Centers, Clinics) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).
Surgical Drainage Devices Market Segmentation
By Product Type:
- Active drains
- Passive drains
By Application:
- Thoracic and Cardiovascular Surgeries
- Neurosurgical Procedures
- Abdominal Surgery
- Orthopedics
- Other Applications
By End-Use:
- Hospitals
- Ambulatory Surgical Centers
- Clinics
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15869
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
